GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosolution Co Ltd (XKRX:086820) » Definitions » Ending Cash Position

Biosolution Co (XKRX:086820) Ending Cash Position : ₩0 Mil (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Biosolution Co Ending Cash Position?

Biosolution Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ₩0 Mil.

Biosolution Co's quarterly Ending Cash Position increased from Sep. 2024 (₩8,509 Mil) to Dec. 2024 (₩12,922 Mil) but then declined from Dec. 2024 (₩12,922 Mil) to Mar. 2025 (₩0 Mil).

Biosolution Co's annual Ending Cash Position declined from Dec. 2022 (₩13,444 Mil) to Dec. 2023 (₩5,486 Mil) but then increased from Dec. 2023 (₩5,486 Mil) to Dec. 2024 (₩12,922 Mil).

Biosolution Co Ending Cash Position Historical Data

The historical data trend for Biosolution Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosolution Co Ending Cash Position Chart

Biosolution Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,392.70 28,956.26 13,443.56 5,485.71 12,921.63

Biosolution Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,251.03 13,065.40 8,509.46 12,921.63 -

Biosolution Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biosolution Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=5485.71+7435.921
=12,922

Biosolution Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0

Biosolution Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biosolution Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosolution Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosolution Co Ltd (XKRX:086820) » Definitions » Ending Cash Position
Comparable Companies
XKRX:475960 XKRX:308430 XKRX:127120 XKRX:095700 XKRX:323990 XKRX:138610 XKRX:048870 XKRX:394800 XKRX:065660 XKRX:203400 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Gongneung-Ro 232, Nowon-gu, 5th Floor, Room 519, Seoul Technopark, Seoul, KOR
Website
http://www.biosolutions.co.kr
Biosolution Co Ltd is a Korean company offering Cell-Based Biotechnology. It is engaged in manufacturing and selling cell therapy products, and developing cell therapeutics technology. Its main areas include cell-based therapeutics with their background in somatic and stem cell technology, and the manufacturing, sales, and R&D of human tissue models for screening toxicity and efficacy with tissue engineering technology.

Biosolution Co Headlines

No Headlines